Home/Pipeline/LiquidHALLMARK

LiquidHALLMARK

Solid Tumors (therapy selection & MRD)

CommercialActive

Key Facts

Indication
Solid Tumors (therapy selection & MRD)
Phase
Commercial
Status
Active
Company

About Lucence Diagnostics

Singapore‑born precision‑diagnostics firm delivering AI‑enhanced liquid‑biopsy and early‑cancer detection tests.

View full company profile

Therapeutic Areas